EPISODE · Aug 21, 2024 · 21 MIN
Market View: Eli Lilly, Novo Nordisk, JD.com, Johnson & Johnson, Lowe's, SATS, StarHub, and Gold
from Your Money with Michelle Martin · host MONEY FM 89.3
Join Michelle Martin on her tour of markets! Today's discussion covers Eli Lilly's latest drug study results and competition with Novo Nordisk. Learn about JD.com's share price drop, Johnson & Johnson's acquisition, and Lowe's revised outlook. SATS’ return to profitability and StarHub's recent broadband outage are also on the agenda. Plus, discover insights into gold's record highs and China's growing nuclear power investments with Michelle and IG Markets Yeap Jun Rong. See omnystudio.com/listener for privacy information.
NOW PLAYING
Market View: Eli Lilly, Novo Nordisk, JD.com, Johnson & Johnson, Lowe's, SATS, StarHub, and Gold
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m